High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study

BACKGROUND: Helicobacter pylori (H. pylori) infection is important risk factors for chronic gastritis, peptic ulcer and gastric cancer. Bismuth-containing quadruple therapy has recently been the first-line regimen recommended in many European countries but has limited efficacy in ASEAN especially Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Poonyam, Piyakorn, Chotivitayatarakorn, Peranart, Vilaichone, Ratha-Korn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976817/
https://www.ncbi.nlm.nih.gov/pubmed/31554388
http://dx.doi.org/10.31557/APJCP.2019.20.9.2859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976817/
https://www.ncbi.nlm.nih.gov/pubmed/31554388
http://dx.doi.org/10.31557/APJCP.2019.20.9.2859

Ejemplares similares